We note the very high levels of surface IL-7R expression on fetal B cells; activating mutations in the IL-7 pathway are common second hits in pediatric ALL, suggesting that this survival pathway may have relevance in the in utero initiation of B-ALL (Shochat et al., 2011). Here, IL7 is linked to acute lymphoblastic leukemia.